 Jeffrey Glasheen
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 15 | 2022 | 172 | 3.320 |
Why?
| | Internal Medicine | 10 | 2016 | 211 | 1.970 |
Why?
| | Internship and Residency | 9 | 2022 | 920 | 1.670 |
Why?
| | Leadership | 3 | 2022 | 291 | 1.330 |
Why?
| | Hospital Medicine | 3 | 2022 | 82 | 1.330 |
Why?
| | Warfarin | 6 | 2011 | 136 | 1.290 |
Why?
| | Academic Medical Centers | 7 | 2017 | 405 | 1.270 |
Why?
| | Quality Improvement | 6 | 2022 | 944 | 1.220 |
Why?
| | Anticoagulants | 5 | 2008 | 547 | 0.960 |
Why?
| | Career Mobility | 2 | 2017 | 61 | 0.900 |
Why?
| | Education, Medical, Undergraduate | 2 | 2021 | 160 | 0.900 |
Why?
| | Levofloxacin | 4 | 2008 | 22 | 0.860 |
Why?
| | Ofloxacin | 4 | 2008 | 22 | 0.860 |
Why?
| | Hospitalization | 5 | 2023 | 1762 | 0.830 |
Why?
| | Models, Educational | 2 | 2015 | 82 | 0.770 |
Why?
| | Hospital Costs | 2 | 2011 | 104 | 0.720 |
Why?
| | Hemorrhage | 3 | 2008 | 600 | 0.620 |
Why?
| | Education, Medical | 3 | 2015 | 214 | 0.560 |
Why?
| | Clinical Competence | 3 | 2015 | 882 | 0.560 |
Why?
| | Mentors | 4 | 2022 | 155 | 0.520 |
Why?
| | Stroke | 5 | 2015 | 1019 | 0.510 |
Why?
| | Patient Discharge | 5 | 2016 | 770 | 0.500 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 99 | 0.500 |
Why?
| | Patient Handoff | 1 | 2015 | 26 | 0.480 |
Why?
| | Medicaid | 2 | 2016 | 404 | 0.480 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 88 | 0.470 |
Why?
| | Efficiency | 2 | 2011 | 84 | 0.450 |
Why?
| | Faculty, Medical | 3 | 2016 | 226 | 0.440 |
Why?
| | International Normalized Ratio | 4 | 2008 | 42 | 0.430 |
Why?
| | Practice Patterns, Physicians' | 2 | 2011 | 1175 | 0.420 |
Why?
| | Perception | 1 | 2015 | 309 | 0.400 |
Why?
| | Job Satisfaction | 3 | 2022 | 168 | 0.390 |
Why?
| | Hospitals | 2 | 2023 | 581 | 0.380 |
Why?
| | Medicare | 3 | 2015 | 661 | 0.380 |
Why?
| | Hospitals, University | 1 | 2011 | 169 | 0.360 |
Why?
| | Cooperative Behavior | 2 | 2011 | 376 | 0.350 |
Why?
| | Polypharmacy | 1 | 2011 | 74 | 0.350 |
Why?
| | Humans | 42 | 2023 | 114045 | 0.350 |
Why?
| | Patient Readmission | 2 | 2013 | 607 | 0.340 |
Why?
| | Burnout, Professional | 3 | 2011 | 323 | 0.310 |
Why?
| | Anti-Bacterial Agents | 2 | 2008 | 1471 | 0.310 |
Why?
| | Delivery of Health Care | 2 | 2021 | 828 | 0.300 |
Why?
| | Ischemic Attack, Transient | 1 | 2009 | 62 | 0.300 |
Why?
| | Curriculum | 5 | 2022 | 813 | 0.300 |
Why?
| | Inservice Training | 1 | 2009 | 106 | 0.300 |
Why?
| | Physicians | 2 | 2015 | 765 | 0.290 |
Why?
| | Dysentery | 1 | 2007 | 1 | 0.290 |
Why?
| | Patient Care Team | 1 | 2011 | 517 | 0.270 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2008 | 119 | 0.260 |
Why?
| | Career Choice | 2 | 2022 | 178 | 0.260 |
Why?
| | Communication | 1 | 2011 | 734 | 0.250 |
Why?
| | Length of Stay | 3 | 2016 | 957 | 0.240 |
Why?
| | Acidosis, Lactic | 1 | 2005 | 27 | 0.240 |
Why?
| | Feces | 1 | 2007 | 372 | 0.240 |
Why?
| | Drug Interactions | 4 | 2008 | 337 | 0.240 |
Why?
| | Blood Pressure | 2 | 2009 | 1531 | 0.230 |
Why?
| | Burkitt Lymphoma | 1 | 2005 | 52 | 0.230 |
Why?
| | Stress, Psychological | 1 | 2011 | 944 | 0.220 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 219 | 0.210 |
Why?
| | Hypercapnia | 1 | 2002 | 50 | 0.210 |
Why?
| | Hypothyroidism | 1 | 2002 | 65 | 0.200 |
Why?
| | Primary Health Care | 1 | 2011 | 1502 | 0.190 |
Why?
| | Academies and Institutes | 1 | 2022 | 44 | 0.190 |
Why?
| | Organizational Innovation | 2 | 2015 | 132 | 0.190 |
Why?
| | Emergency Service, Hospital | 1 | 2011 | 1815 | 0.180 |
Why?
| | Hypoglycemia | 1 | 2005 | 386 | 0.180 |
Why?
| | United States | 7 | 2016 | 12137 | 0.170 |
Why?
| | Risk Assessment | 1 | 2009 | 2958 | 0.170 |
Why?
| | Inpatients | 1 | 2023 | 378 | 0.170 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 224 | 0.160 |
Why?
| | Program Evaluation | 1 | 2022 | 820 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4402 | 0.140 |
Why?
| | Hospital Mortality | 2 | 2021 | 773 | 0.140 |
Why?
| | Insurance, Health | 2 | 2015 | 243 | 0.130 |
Why?
| | Students | 1 | 2021 | 499 | 0.130 |
Why?
| | Retrospective Studies | 7 | 2021 | 12521 | 0.130 |
Why?
| | Uncompensated Care | 1 | 2015 | 18 | 0.130 |
Why?
| | Aged | 8 | 2015 | 18969 | 0.120 |
Why?
| | Medically Uninsured | 1 | 2015 | 122 | 0.120 |
Why?
| | Mentoring | 1 | 2016 | 99 | 0.120 |
Why?
| | Hospitals, Special | 1 | 2013 | 10 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1310 | 0.110 |
Why?
| | Female | 13 | 2022 | 59324 | 0.110 |
Why?
| | Male | 12 | 2016 | 55396 | 0.100 |
Why?
| | Workload | 2 | 2011 | 131 | 0.100 |
Why?
| | Risk Factors | 5 | 2015 | 8614 | 0.100 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 185 | 0.100 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 252 | 0.090 |
Why?
| | Time Factors | 2 | 2011 | 6077 | 0.090 |
Why?
| | Health Services for the Aged | 1 | 2011 | 70 | 0.090 |
Why?
| | Specialties, Surgical | 1 | 2011 | 67 | 0.090 |
Why?
| | Adult | 7 | 2022 | 30375 | 0.090 |
Why?
| | Cerebral Hemorrhage | 1 | 2011 | 96 | 0.090 |
Why?
| | Patient Safety | 1 | 2013 | 273 | 0.090 |
Why?
| | Blood Cell Count | 1 | 2009 | 50 | 0.080 |
Why?
| | Speech Disorders | 1 | 2009 | 30 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 204 | 0.080 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2007 | 79 | 0.080 |
Why?
| | Data Collection | 1 | 2011 | 618 | 0.080 |
Why?
| | Histamine H1 Antagonists | 1 | 2008 | 28 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2009 | 87 | 0.070 |
Why?
| | Neurology | 1 | 2009 | 85 | 0.070 |
Why?
| | Geriatrics | 1 | 2008 | 69 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2009 | 180 | 0.070 |
Why?
| | Models, Organizational | 1 | 2008 | 140 | 0.070 |
Why?
| | Critical Care | 1 | 2011 | 472 | 0.070 |
Why?
| | Disabled Persons | 1 | 2009 | 130 | 0.070 |
Why?
| | Benzodiazepines | 1 | 2008 | 114 | 0.070 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 133 | 0.070 |
Why?
| | Internet | 1 | 2011 | 591 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2008 | 195 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 544 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 561 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 221 | 0.060 |
Why?
| | Ultrasonography | 1 | 2009 | 635 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 24 | 0.060 |
Why?
| | Lipids | 1 | 2009 | 564 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 629 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 38 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 325 | 0.060 |
Why?
| | Azithromycin | 1 | 2005 | 80 | 0.060 |
Why?
| | Middle Aged | 4 | 2015 | 26605 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1791 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2005 | 281 | 0.060 |
Why?
| | Tumor Burden | 1 | 2005 | 258 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2011 | 4595 | 0.060 |
Why?
| | Thrombosis | 1 | 2007 | 295 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2007 | 428 | 0.060 |
Why?
| | Cohort Studies | 2 | 2021 | 4883 | 0.060 |
Why?
| | Referral and Consultation | 1 | 2008 | 632 | 0.060 |
Why?
| | Prospective Studies | 3 | 2023 | 6195 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2005 | 438 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 662 | 0.050 |
Why?
| | Administration, Oral | 1 | 2005 | 725 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2005 | 248 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 249 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2023 | 150 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1204 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 2885 | 0.050 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 395 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 144 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 739 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 949 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2007 | 970 | 0.040 |
Why?
| | Hypertension | 1 | 2007 | 1052 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2009 | 9049 | 0.030 |
Why?
| | Colorado | 3 | 2013 | 4090 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 799 | 0.030 |
Why?
| | Medicine | 1 | 2016 | 102 | 0.030 |
Why?
| | Young Adult | 1 | 2008 | 10444 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 192 | 0.030 |
Why?
| | Education | 1 | 2013 | 93 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2013 | 193 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2013 | 575 | 0.020 |
Why?
| | Comprehension | 1 | 2013 | 151 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6306 | 0.020 |
Why?
| | Medical Audit | 1 | 2011 | 75 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 614 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 160 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 198 | 0.020 |
Why?
| | Self Care | 1 | 2013 | 350 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2011 | 117 | 0.020 |
Why?
| | Sepsis | 1 | 2015 | 507 | 0.020 |
Why?
| | Self Efficacy | 1 | 2013 | 353 | 0.020 |
Why?
| | Palliative Care | 1 | 2015 | 641 | 0.020 |
Why?
| | Training Support | 1 | 2008 | 22 | 0.020 |
Why?
| | Work Schedule Tolerance | 1 | 2005 | 35 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2005 | 572 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2384 | 0.010 |
Why?
|
|
Glasheen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|